PharmExec Direct eNewsletter

PharmExec Direct:
Having trouble viewing this e-mail? Click here.

You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile

PharmExec Direct | From the editors of Pharmaceutical Executive

April 7, 2011 | ISSUE NUMBER 194 VOL 8

Healthcare Reform
Financing the Future of Drug Innovation
Howard Dean, former Vermont governor and Chair of the Democratic National Committee, adds some additional twists to the healthcare reform debate.

Featured Case Studies:

Infosys’ SAP Life Sciences Success stories
Success stories of SAP programs for large Life Sciences companies encompassing Transformational engagements, Upgrades, Support and Compliance Management – A must read for Life Sciences companies leveraging SAP for their business success.

Regulatory
How Will Accountable Care Organizations Impact Drug Sales?
Pharma companies hoping to do business with ACOs will have to show that expensive branded drugs can offer not just better health outcomes, but also system-wide savings.

Patents
Patent Reform: Round 2
Pharma and biotech gear up for another round of debates on patent reform as the US House of Representatives begins consideration of proposed legislation.

Biotechnology
Biotech’s Brighter Future
New BIO report proposes creative solutions to the problems currently facing the industry.

// PA Consulting Group (New York) announced that Jordan Cohen joined its US operations as Director of the Life Sciences and Healthcare practice. Cohen most recently served as Senior Director and Head of pfizerWorks at Pfizer. // Lithera (San Diego), a clinical stage company developing pharmaceutical and biomedical products, announced the appointment of Thomas G. Wiggans to its Board of Directors. // Daiichi Sankyo (Parsippany, NJ) appointed John P. Gargiulo as President and CEO. Gargiulo succeeds Joseph P. Pieroni, who is retiring after leading Daiichi Sankyo Group’s US commercial operations for the past 14 years. //

April 21: Annual Healthcare Symposium
Newark, N.J.

May 5: Healthcare Businesswomen’s Association Woman of the Year
Fairfield, N.J.

June 21–22: Life Sciences CRM Forum
Philadelphia

June 27–29: Digital Pharma West
San Francisco

Which Big Pharma is poised to hit the $40 billion mark in Rx sales for 2010?

EMA Sides with Former Executive Director

Alzheimer’s Advances Depend on Early Diagnosis

Read the Pharm Exec Global Digest Here


	Follow Pharm Exec on Twitter
	Follow Pharm Exec on Facebook

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.